WallStSmart
FEED

ENvue Medical Inc.

NASDAQ: FEED · HEALTHCARE · MEDICAL DEVICES

$1.16
+0.00% today

Updated 2026-04-30

Market cap
$4.96M
P/E ratio
P/S ratio
1.94x
EPS (TTM)
$-26.69
Dividend yield
52W range
$1 – $47
Volume
3.4M

ENvue Medical Inc. (FEED) Stock Valuation Analysis

Fair value estimate, historical valuation range, and quality signals for FEED.

WallStSmart Verdict
Overvalued

Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.

Smart Value Score: 30 / 100
P/E (TTM)
Not meaningful for this profile
PEG
Margin of Safety
+8.45%
Fair value $2.96 vs $1.16
EV / EBITDA
0.0x

FEED historical valuation range

Where current P/E sits in FEED's own 5Y range.

Insufficient historical data for 5Y percentile analysis

FEED intrinsic value (DCF)

DCF-based fair value estimate vs current market price.

Current price
$1.16
Market value
Intrinsic value
$2.96
DCF estimate
Margin of safety
+8.45%
+155.2% upside to fair value

Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.

FEED valuation signals

Quick-read green flags, caution flags, and risks based on current metrics.

!
Near fair value
+8.45% margin of safety. Price is close to DCF estimate.
Weak financial quality
Piotroski F-Score of 0/9 suggests deteriorating fundamentals. Valuation requires closer scrutiny.

P/E Ratio — History

No historical P/E data available

P/S Ratio — History

Current: 1.94x

Is FEED overvalued in 2026?

ENvue Medical Inc. (FEED) currently trades at $1.16 per share with a market capitalization of $4,959,200.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 30/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.

FEED currently has no meaningful P/E ratio, which typically signals that the company is unprofitable, near breakeven, or emerging from a loss-making period. With a P/S ratio of 1.9x, the market is valuing the company primarily on its revenue rather than its earnings.

Our discounted cash flow model estimates FEED's intrinsic value at $2.96 per share, against the current market price of $1.16. This implies a margin of safety of +8.45%. The stock is priced close to its estimated fair value, offering limited upside without further operational improvement.

Financial quality is a concern. The Piotroski F-Score of 0/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.

Bottom line: FEED appears richly valued on our framework, with a Smart Value Score of 30/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.

Frequently asked questions

Is FEED overvalued in 2026?

Based on a Smart Value Score of 30/100, FEED appears overvalued. Current price exceeds what fundamentals currently justify.

What is FEED's fair value?

Our DCF model estimates FEED's intrinsic value at $2.96 per share, versus the current price of $1.16. This produces a margin of safety of +8.45%.

What P/E ratio does FEED trade at?

FEED does not have a meaningful P/E ratio at this time, typically a sign of unprofitability or an ongoing earnings transition.

Is FEED a buy based on valuation?

WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 30/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.

How does FEED's valuation compare to its history?

Insufficient historical valuation data exists yet for a confident percentile read on FEED.

What is FEED's Smart Value Score?

FEED's Smart Value Score is 30/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.